Beyond the AJR: "Aggregated Tau Measured by Visual Interpretation of Flortaucipir Positron Emission Tomography and the Associated Risk of Clinical Progression of Mild Cognitive Impairment and Alzheimer Disease: Results From 2 Phase III Clinical Trials"

AJR Am J Roentgenol. 2022 Jan;218(1):192. doi: 10.2214/AJR.21.26174. Epub 2021 May 12.
No abstract available

Publication types

  • Comment

MeSH terms

  • Alzheimer Disease* / diagnostic imaging
  • Cognitive Dysfunction* / diagnostic imaging
  • Disease Progression
  • Humans
  • Positron-Emission Tomography

Substances

  • 7-(6-fluoropyridin-3-yl)-5H-pyrido(4,3-b)indole